Results for tag: "Cachexia Drug"

Cachexia is a condition associated with cancer and other chronic diseases that is characterized by a severe loss of muscle and fat tissue. It is a major cause of morbidity and mortality in cancer patients, and is estimated to affect up to 80% of cancer patients. Cachexia is caused by a combination of factors, including anorexia, inflammation, and metabolic changes. Treatment of cachexia is challenging, as it is often difficult to distinguish between the effects of the underlying disease and the effects of the cachexia itself. The cachexia drug market is a rapidly growing segment of the oncology drug market. Cachexia drugs are designed to improve the quality of life of cancer patients by reducing the symptoms of cachexia, such as anorexia, fatigue, and muscle wasting. These drugs are typically used in combination with other treatments, such as chemotherapy and radiation therapy. Some companies in the cachexia drug market include Celgene, Merck, Novartis, and Pfizer. Show Less Read more